Laxmi Organic Industries Limited (LXCHEM)
Investor Presentation
AI summary
- Consolidated Q1FY27 revenue 9,683 Mn +40% y-y; EBITDA 1,143 Mn +272%; PAT 677 Mn +216%
- Strong double-digit revenue growth driven by volumes and prices despite volatile markets
- Higher realizations and operating leverage supported margin expansion; EBITDA margin 11.8% (+740 bps)
- Ethyl Acetate new capacity at Lote commissioned; Dahej Phase II capex progressing on schedule
- Focus on customer engagement, procurement efficiency, and execution discipline
- Specialties business has strong new product pipeline
- Exports remain relevant with 35% revenue share in Q1FY27
- Management emphasizes sustainability and innovation with 65+ R&D staff
- Strategic shift to customer-centric approach driving market share gains
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 LXCHEM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add LXCHEM to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Laxmi Organic Industries Limited
Important.
The summary above is generated automatically from Laxmi Organic Industries Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.